You can buy or sell Acer and other stocks, options, ETFs, and crypto commission-free!
Acer Therapeutics Inc. Common Stock (DE), also called Acer, is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Read More Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling in September 2017 and is headquartered in Newton, MA.
52 Week High
52 Week Low
Simply Wall StFeb 22
Loss-Making Acer Therapeutics Inc. (NASDAQ:ACER) Expected To Breakeven
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Acer Therapeutics Inc.’s (NASDAQ:ACER): Acer Therapeutics Inc., a pharmaceutical company, develops therapies for the treatment of rare diseases with critical unmet medical needs. The company’s loss has recently broadened since it announced a -US$14.2m loss in the full financial year, compared to the latest trailing-twelve-month loss of -US$17.0m, moving it further away from breakeven. Many inves...
-$0.46 per share
-$0.85 per share